Clinical Trial Update: Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

View source ↗

Summary

An update on a clinical trial investigating predictive biomarkers for IGF1R-targeted therapy in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Ovarian Cancer | Status: UNKNOWN